* The fixation of risèdronates on the bioactive glass surface has been highlighted. * Scanning electron microscopy shows the new morphology of this composite * Chemical analyses reveal the stability of adsorption process after 40 min of incubation.
can be implanted alone then it can be associated with other composites such as biomaterial.
Biomaterial is a huge area, as it contains tricalcium phosphate, hydroxypatite [12, 13] , calcium phosphate and bioactive glasses [14, 15] .
Bioactive glasses are a group of surface reactive glass-ceramic biomaterials and include original bioactive glass. This group of glasses was later termed "bioactive", being "a material that elicits a specific biological response to the material surface which results in the formation of a bond between the tissues and the materials" [16, 17] . The adhesion of bioactive glass with other molecules involves several processes such as adsorption. There are several studies have been done on the adsorption of organic molecules (therapeutic agent) on apatite surface [18, 19] nevertheless, nearly no study has been interested in the association of therapeutic molecule with bioactive glass by adsorption phenomenon. For this reason, the aim of this work was to combine the therapeutic agents, as risedronates, in bioactive glass to synthesize a composite to be used as a bone graft. The incorporation of risedronate into bioactive glass to form bioactive glass/risedronate composite has been achieved using the adsorption process. This paper describes the elaboration of this hybrid material and the interactions between bioactive glass and risedronate. To achieve this, we adopted a global approach using complementary physicochemical techniques such as FTIR, RAMAN and Solid MAS-NMR spectroscopy in order to learn more about the interaction processes of risedronate with bioactive glass surface.
Materials and methods
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Synthesis of bioactive glass
Bioactive glasses were synthesized by freeze-drying method. Chemical compositions of glass were 46 mass % SiO 2 (silica), 24 mass % CaO (calcium oxide or lime), 24 mass % Na 2 O (Sodium oxide) and 6 mass % P 2 O 5 (Phosphorus pentoxide). The premixed mixtures were melted in platinum crucibles to avoid the risk of contamination. The fusion temperature of platinum is of 1760°C for that it resists to these of the 46S6 (1300°C). The first rise of temperature rate was 10°C min -1 and was held at 900°C for 1 hour until the decarbonatation of all products. The second rise of temperature rate was 20°C/min and it was hold to 1300°C for 3 hours. The samples were casted in preheated brass molds, in order to form cylinders of 13 mm in diameter, and annealed at 565°C for 4 hours near the glass transition temperature. This glass was then ground using a milling machine, and sieved to obtain particles with a size distribution of 40 μm.
Adsorption experiments
Adsorption experiments were carried out at physiological temperature (37 ± 1 .C), by dispersing 50 mg of bioactive glass powder in 5 mL of risedronate solutions (concentration ranging from 0.8 to 2 mM) in a polyethylene tube. The latter were prepared by dissolving the appropriate amount of risedronate in an aqueous 1 mM KCl solution (standard solution); the pH of the obtained solutions was adjusted to 7.4 using hydrochloric acid and potassium hydroxide solutions. After sonication for 1-3 min, the suspensions were incubated for 20, 40, 60 and 80 min without stirring and centrifuged for 20 min at 15000 rpm. Two Blanks were used: the first contains only the risedronate prepared and incubated in the solutions corresponding to the adsorption tests but without bioglass while the second consists of the bioactive glass also prepared and incubated in the solution. After centrifugation, the obtained A c c e p t e d M a n u s c r i p t 6 solids were washed with deionised water and lyophilised. The supernatants were filtrated on millipore filters (0.2 μm). Thus we obtained three hybrid materials: 46S6-8RIS, 46S6-12 RIS and 46S6-20RIS.
Solid phase characterization
Several physicochemical methods were employed for the characterization of the prepared bioactive glass/ risedronate composite. Phase analysis was examined by X-ray diffraction analyses were performed on ~ 1 mg of materials with metallic blade. Spectra were obtained between 4000 and 400 cm -1 wavenumber, with a resolution of 2cm -1 . Raman spectra of the samples were generated on a Horiba, Jobin-Yvon Labram HR800 confocal microspectrometer, equipped with a helium-neon LASER (λ= 632.82 nm). The spectral resolution was 2 cm -1 , the laser power was 2 mW and integration times varied from 30 to 120 s. All spectra were recorded over a wavelength range of 200-1800 cm -1 . Three spectral accumulations were averaged. Nuclear Magnetic Resonance (MASS) using Bruker MAS spectrometer ASX300 (7.05 T) was employed to highlight the microstructure of all compounds and finally Scanning Electron Microscopy (SEM) using Jeol JSM 6301F was used for the morphology investigations.
Solution analysis
The silicon content of the solutions obtained after adsorption experiment was measured by inductively coupled plasma-Optical Emission Spectrometry (ICP-OES) method. The risedronate concentration in the filtrates was determined using UV spectrophotometric absorption at 262 nm (Hewlett Packard 8452A Diode Array Spectrophotometer). This This was due to the association method (adsorption) which is a surface phenomenon.
Moreover adsorption is the adhesion of atoms, ions, or molecules from a dissolved solid to a surface. It is a surface-based process [24] 
FTIR spectroscopy
Infrared spectra of the bioactive glass (46S6), risedronate (RIS) and of composites 46S6- It highlights the presence of a small amount of phosphate linked to the silica network [25] [26] [27] .
The infrared spectrum of risedronate illustrates the presence of several bands, therefore we note the presence of C = O bands at 1700 cm -1 and 1130 cm -1 . Also we remark the presence of C = N, C = C and C-N = O bands respectively at 1200 cm -1 (amide), 1666 cm -1 and 1570 cm -1 . Finally, we observe the presence of P-O band at 537 and 468 cm -1 [22] . The risedronate sodium salt showed two intense bands in the 1025-1055 cm -1 region assigned to C-H pyridine ring deformation, strongly impacted by hydrogen bonding between the pyridine ring and an adjacent phosphate group [28] .
Infrared spectra of all composites 46S6-20RIS after 20 min, 40 min, 60 min and 80 min illustrate the presence of bands characterizing 46S6 and RIS. Thus, these composites reveal the presence of Si-O band at 503 cm -1 which was slightly shifted and decreased of intensity.
Also we note the existence of two bands of C=O, the first at 1700 cm -1 which was slightly shifted to the right and the second at 1130 cm-1 this was with a slight intensity. We remark also the presence of C = N, C = C and of C-N = O bands respectively at 1200 cm -1 (amide), other data reported by Barroug [22] during the association between nanocrystalline apatites and risedronate. Also this finding illustrates the interaction between bioactive glass and bisphosphonates, thus this result coincide with other studies [31] . Then, we remark the presence of C-P bands at 612 and 814 cm -1 and also the appearance of two bands of P-OH at 849 and 872 cm -1 . At the same time we observe the presence of the three bands of bioactive glass at the raman shifts respectively 347, 624 and 942 cm -1 . These details clarify the association of risedronate with bioglass ( Figure 5 ). ( Figure 6 and Table 1 ).
NMR spectroscopy
The same result is reported by RAMAN spectroscopy. Then, after the association of 8%
risedronates with bioactive glass, there are no additional band to 46S6 Raman spectratum and no new compound in 31 P MAS-NMR are revealed whereas after the association of 12% and 20% risedronate we note the appearance of new bands characterizing risedronate in the RAMAN spectratum and the appearance of new compounds in 31 P MAS-NMR corresponding to risedronates species. These findings could be explained by the few quantity of risedronate added to 46S6 material in the composite 46S6-8 RIS.
Findings reported by 46S6-12 RIS and 46S6-20 RIS are in conformity with the results reported by Barroug [22] , after the association of risedronate to the nanocrystalline apatites and which proved by the appearance of risedronate compounds in the spectratum of the composite risedronate -naocrystalline apatites.
Morphological study by scanning electron microscopy (SEM) coupled with energy-dispersive X-ray:
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The obtained results are shown in Figure 7A , 7B and 7C. The surface of 46S6 displays smooth fragments while the composite 46S6-XRIS exhibit rough surface. The risedronate crystals on the surfaces of composite are well observed. They adhered to the bioactive glass particles and created some interstices on the surface of the 46S6-XRIS composite. The risedronate molecules modify strongly the surface morphology of pure bioactive glass. They are found almost everywhere on the surface of the 46S6-XRIS composite due to their chemical affinity for calcium ions in the matrix of bioactive glass. Therefore, the combination of 8% and 12% of RIS with 46S6 shows the presence of the filaments coming encompass the bioactive glass blocks whereas after the association of 20% RIS with 46S6, the bioactive glass blocs is nearly encompassed by risedronate filaments. The same result is seemed after the association of risedronate with the nanocrystalline-apatite [22] and after the association of zoledronate with bioactive glass [33] . Thus, all these input illustrate the reactivity and the good chemical binding and interaction with other molecules of pure bioactive glass.
Result reported by energy-dispersive X-ray showed the decreasing of Si quantities in the 46S6-XRIS surface with the increasing of risèdronates associated with 46S6. Thus, this result highlights the SEM data. Therefore, the Si quantity decreased from 6.6 in 46S6-8RIS to 1.8 in 46S6-20RIS. This results illustrates that 46S6-20RIS surface is nearly covered by risèdronates ( Figure 8 : A,B, C).
Analysis of the solutions after uptake of risedronates (solution obtained after the filtration)
Analyses of the obtained solutions after uptake of rideronate divulged that the binding of risedronate ions to the bioactive glass surface affected the amount of silicon ion in the solution. The evolution of this ion in solution as a function of risedronate adsorbed onto 46S6 surface in Figure 9 . The release of silicon ion increased upon uptake of risedronate. The
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A c c e p t e d M a n u s c r i p t 13 content of silicon ions in solution for the 46S6-20 RIS was significantly higher due to the specific solubility behavior of this type of biomaterial and the high quantity of risedronates which fixed in the silicon sites. These observations suggest that risedronate molecules substituted for silicon ions on the 46S6 surface. Several studies illustrate that the fixation of BP is accompanied by the release of some elements from the adsorbent surface such as the liberation of silicon and phosphorus. As reported by several authors [34, 35] for other BP, it can be postulated that risedronate species participate in an ionic exchange process with active mineral ions on the surfaces of bioactive glass, particularly silicon, which share the same ionic sites at the surface. Silicon intervenes in several physicochemical properties after its immersion in the SBF solution or after its in vivo experiment. Consequently, the rate of bone formation at a bioactive glass implant interface can be altered by changing the glass composition [36, 37] . However, the release of phosphorus decreased with time incubation, this attenuation is explained by the reduction of risedronate phosphorus in the solution. Thus, this explained by the decreasing of phosphorus in the solution in favor of the increasing of risedronates fixation in the 46S6 surface ( Figure 10 )
The binding of risedronate with bioactive glass was evaluated by using UV spectrophotometric absorption at a pH= 7.4, temperature = 25 and at a wavenumber λ = 362
nm. This wave number is chieved from the calibration of the solution with 2 mM of risedronate ( Figure 11 ).
The kinetic release of risedronates in KCl during the association of risedronate with bioactive glass was studied by UV visible. Therefore, we note that the release of this molecule reaches its threshold for compounds 46S6-8RIS, 46S6-12RIS and 46S6-20RIS after 40 min of incubation. This result illustrates the maximum attachment of risedronates on 46S6 after 40 min and exhibits the fixation of RIS on the 46S6 surface with a speedy kinetic ( Figure 12 ).
Others similar results were reported by the literature of the interaction of apatite with different M a n u s c r i p t 14 bisphosphonates [38] , with the adenosine 5-monophosphate [39] and with phosphocitrates [40] . This finding explains the high reactivity of the 46S6 surface to the molecules of biological interest. Additionally, this result explains that resedronate presents an early release due to its hydrophilic character, the same results is reported in previous works after the immersion of gentamicin sulfate in the PBS solution [41] .
Ʈ min of 46S6-8RIS, 46S6-12RIS and 46S6-20 RIS system relaxation respectively after 0 min, 20 min, 40 min, 60 min and 80 min for each composite increased between 20 min and 40 min then they were stabilized. This data discloses that risedronates achieve its threshold of release after 40 min ( Figure 13 ).
The comparison of Δ (Ʈ min) of all composites 46S6-8RIS, 46S6-12 RIS and 46S6-20 RIS reveals its increasing with the rise of risedronates quantity added to 46S6.
4-Conclusion:
This study suggests that risedronate adsorption on bioglass supports corresponds to an ion substitution reaction with silicon ions at the crystal surface. This mechanism explains the reactivity of 46S6 surface. Moreover, the association between 46S6 and risedronate is showed by the appearance of bands characterizing 46S6 and risedronate in the composites 46S6-8RIS, 46S6-12RIS and 46S6-20RIS after its characterization by FTIR and RAMAN spectroscopy.
This association is confirmed also by MAS-NMR 31 Ris: risedronates Ris: risedronates 
